3M Company (3M CO) - Q1 2005 10-Q Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2005. 3M is a diversified global manufacturer and technology innovator. Effective January 1, 2005, the company realigned its business segments, transferring the Electronics Markets Materials Division and certain tapes from the Industrial segment to the Electro and Communications segment, and moving converter markets products from Transportation to Display and Graphics. Geographic reporting was also adjusted to move the African Region to the Europe and Middle East area.
Key Financial Metrics
| Metric (in millions, except per share) | Q1 2005 | Q1 2004 |
|---|---|---|
| Net Sales | $5,166 | $4,939 |
| Operating Income | $1,224 | $1,117 |
| Operating Margin | 23.7% | 22.6% |
| Net Income | $809 | $722 |
| Diluted EPS | $1.03 | $0.90 |
| Operating Cash Flow | $1,003 | $942 |
| Total Debt | $2,908 | $2,821 (Dec 31, 2004) |
| Cash & Equivalents | $2,669 | $2,757 (Dec 31, 2004) |
| Net Debt | $204 | $64 (Dec 31, 2004) |
Material Changes vs. Prior Period
- Sales Growth: Net sales increased 4.6% year-over-year, driven by a 2.3% increase in local-currency sales and a 2.3% positive currency translation impact. Volume growth was 1.8%, and price increases contributed 0.5%.
- Profitability: Operating income rose 9.5% to $1.224 billion. Margins expanded due to productivity gains, favorable product mix, and currency benefits, offsetting a 6% increase in raw material costs.
- Segment Performance:
- Health Care: Sales up 7.9%; Operating income up 18.0% (led by Aldara cream growth).
- Electro and Communications: Sales up 1.0%; Operating income surged 34.3% due to restructuring benefits and operational focus despite telecom softness.
- Display and Graphics: Sales up 2.0%; Operating income declined 2.8% due to the phase-out of commercial videotape and declining CRT lens systems.
- Consumer and Office: Sales up 1.8%; Operating income flat, impacted by customers buying ahead of price increases.
- Capital Allocation: The company repurchased $671 million of treasury stock and paid $324 million in dividends. The quarterly dividend was increased by 16.7% to $0.42 per share.
Guidance, Outlook, and Risks
- Outlook: Management expects higher sales growth in optical films, health care, and developing markets for the remainder of 2005. Capital expenditures are projected to be approximately $950 million for the full year.
- Legal Contingencies:
- Asbestos/Respirator Litigation: Accrued liabilities are $232 million with insurance receivables of $437 million. A Mississippi Supreme Court ruling in March 2005 finalized a judgment in 3M's favor regarding a $22.5 million verdict.
- Antitrust: A settlement agreement was substantially negotiated for indirect purchaser class actions regarding transparent tape.
- Accounting Changes: The company plans to adopt SFAS No. 123R (Share-Based Payment) effective January 1, 2006. The impact of EITF 04-08 on diluted EPS is expected to be approximately $0.02 per share annually once effective.
- Risks: Key risks include foreign currency fluctuations (60% of revenue is international), raw material cost volatility, and the outcome of ongoing legal proceedings.
Investor Verification Checklist
- Verify the impact of the new segment structure on year-over-year comparability for Industrial, Electro, and Display segments.
- Monitor the resolution of the indirect purchaser antitrust settlement and its final financial impact.
- Track the status of asbestos litigation reserves versus insurance recoveries, noting the timing differences in cash flows.
- Assess the sustainability of operating margin expansion given the 6% rise in raw material costs.
- Review the adoption timeline and pro-forma impact of SFAS No. 123R on future earnings per share.